Table 2.
CHD risk and stroke risk in subjects depending on gender and the presence or absence of metabolic syndrome.
| Men | Women | |||
|---|---|---|---|---|
| Non-MS | MS | Non-MS | MS | |
| CHD risk (%) | 22.6 ± 14.4 | 28.4 ± 18.3‡ | 11.0 ± 8.4# | 16.2 ± 10.9‡† |
| Fatal CHD risk (%) | 16.4 ± 13.3 | 20.6 ± 17.0‡ | 8.3 ± 7.7# | 12.5 ± 10.3‡† |
| Stroke risk (%) | 9.8 ± 12.0 | 10.6 ± 12.2 | 5.8 ± 6.2# | 8.9 ± 11.3‡∗ |
| Fatal stroke risk (%) | 1.5 ± 2.4 | 1.7 ± 2.2 | 0.8 ± 0.9# | 1.5 ± 2.2‡ |
‡ p < 0.001 compared to subjects of the same gender without MS. # p < 0.001 compared to men without MS. ∗ p < 0.05 and † p < 0.001 compared to men with MS. Data are expressed as mean ± standard deviation. CHD: coronary heart disease; MS: metabolic syndrome.